We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.

We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.
Logo - Business Development Bank of Canada - BDC
Celator Pharmaceuticals Inc. logo
Exited company

Celator Pharmaceuticals Inc.

Details
Region
Atlantic
Industry sector
Medical/health
Investment year
2003
Fund
Diversified Portfolio
Learn more
About the company

Celator is a biopharmaceutical company working to develop new and more effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies designed to target cancer cells. The company’s lead product is in clinical development for the treatment of acute myeloid leukemia.